LUCIUS 卢修斯 色瑞替尼 Ceritinib非小细胞肺癌

色瑞替尼

美国FDA批准上市产品,疗效确切
卢修斯制药(老挝)有限公司出品

Ceritinib

老挝国家食药监局批准上市
老挝国家药检所检测认证

Composition:

Each capsule contains Ceritinib ....... 150mg.
Indication:

LUCIUS

非小细胞肺癌

LuciCer is a kinase inhibitor indicated for the

PHARMACEUTICALS

treatment of patients with metastatic non-
small cell lung cancer (NSCLC) whose
tumors are anaplastic lympnoma kinasc
(ALK)-positive as detected by an FDA

LuciCer

approveu les
130 mg orally once daily. Take LuciCer at
least I hour before or at least 2 hours after a

Ceritinib Capsules

Storage: in a dry place and store at 20°C to

150mg

FDA批准

25°C
Warning:
Keep medicine out of reach of Children. Do

50 Capsules

notadminister LuciCer during Pregnancy

andloustian

PLEASE SEE PACKAGE INSERT
Manufactured and Marketed by
LUCIUS

权威认证

Thongmang village, Xaythany districl.
Vientianc Capital, Laos

www.lueins

Warning : Tobe sold by retail on prescriplion
of registered puysicians only, and as directe

Rx Only

口碑质量

适应症:
适用于经FDA批准的检测方法检测为间变性淋巴瘤

激酶(ALK)呈阳性的转移性非小细胞肺癌
(NSCLC)患者的治疗。
推荐剂量:
每日一次,每次450mg,随餐服用。